Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $2,654,624 (100.0% shares, 0.0% debt)

Holdings (12)

MRNA Moderna Inc 69.3%

Value ($000) $1,840,872 Shares 12,886,743 Est. Cost $16.43 Unrealized +769.8%

SANA Sana Biotechnology Inc 8.3%

Value ($000) $220,158 Shares 34,239,018 Est. Cost $32.56 Unrealized -80.4%

FHTX Foghorn Therapeutics Inc 6.5%

Value ($000) $172,368 Shares 12,674,120 Est. Cost $19.16 Unrealized -32.6%

— Evelo Biosciences Inc 4.0%

Value ($000) $106,401 Shares 50,427,328 Est. Cost $5.89 Unrealized —

— Omega Therapeutics Inc 3.7%

Value ($000) $98,428 Shares 25,902,269 Est. Cost $18.85 Unrealized —

DNLI Denali Therapeutics Inc 2.9%

Value ($000) $77,106 Shares 2,619,968 Est. Cost $17.97 Unrealized +45.8%

— Seres Therapeutics Inc 1.9%

Value ($000) $49,319 Shares 14,378,802 Est. Cost $8.55 Unrealized —

— Axcella Health Inc 1.4%

Value ($000) $38,302 Shares 18,867,785 Est. Cost $6.29 Unrealized —

— Rubius Therapeutics Inc 1.2%

Value ($000) $32,731 Shares 38,506,526 Est. Cost $24.00 Unrealized —

— Sigilon Therapeutics Inc 0.3%

Value ($000) $8,608 Shares 10,370,369 Est. Cost $48.03 Unrealized —

— Codiak Biosciences Inc 0.3%

Value ($000) $7,510 Shares 2,607,303 Est. Cost $32.30 Unrealized —

— Syros Pharmaceuticals Inc 0.1%

Value ($000) $2,821 Shares 2,938,494 Est. Cost $13.87 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	12,886,743	$1,840,872	69.3%	$16.43	+769.8%	COM	60770K107
SANA	Sana Biotechnology Inc	34,239,018	$220,158	8.3%	$32.56	-80.4%	COM	799566104
FHTX	Foghorn Therapeutics Inc	12,674,120	$172,368	6.5%	$19.16	-32.6%	COM	344174107
—	Evelo Biosciences Inc	50,427,328	$106,401	4.0%	$5.89	—	COM	299734103
—	Omega Therapeutics Inc	25,902,269	$98,428	3.7%	$18.85	—	COM	68217N105
DNLI	Denali Therapeutics Inc	2,619,968	$77,106	2.9%	$17.97	+45.8%	COM	24823R105
—	Seres Therapeutics Inc	14,378,802	$49,319	1.9%	$8.55	—	COM	81750R102
—	Axcella Health Inc	18,867,785	$38,302	1.4%	$6.29	—	COM	05454B105
—	Rubius Therapeutics Inc	38,506,526	$32,731	1.2%	$24.00	—	COM	78116T103
—	Sigilon Therapeutics Inc	10,370,369	$8,608	0.3%	$48.03	—	COM	82657L107
—	Codiak Biosciences Inc	2,607,303	$7,510	0.3%	$32.30	—	COM	192010106
—	Syros Pharmaceuticals Inc	2,938,494	$2,821	0.1%	$13.87	—	COM	87184Q107